 | Up a level |
Früh, Martin; Cathomas, Richard; Siano, Marco; Tscherry, Gregor; Zippelius, Alfred; Mamot, Christoph; Erdmann, Andreas; Krasniqi, Fatima; Rauch, Daniel; Simcock, Mathew; Küttel, Erika; Fustier, Pierre; Pless, Miklos; Swiss Group for Clinical Cancer Research, (2013). Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08). Clinical lung cancer, 14(1), pp. 34-39. Elsevier 10.1016/j.cllc.2012.04.001
Ghadjar, Pirus; Simcock, Mathew; Studer, Gabriela; Allal, Abdelkarim S; Ozsahin, Mahmut; Bernier, Jacques; Töpfer, Michael; Zimmermann, Frank; Betz, Michael; Glanzmann, Christoph; Aebersold, Daniel M (2012). Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: 10-Year Follow-up of a Randomized Phase III Trial (SAKK 10/94). International journal of radiation oncology, biology, physics, 82(2), pp. 524-31. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2010.07.105
Ghadjar, Pirus; Bojaxhiu, Beat; Simcock, Mathew; Terribilini, Dario; Isaak, Bernhard; Gut, Philipp; Wolfensberger, Patrick; Brömme, Jens O; Geretschläger, Andreas; Behrensmeier, Frank; Pica, Alessia; Aebersold, Daniel M (2012). High Dose-Rate Versus Low Dose-Rate Brachytherapy for Lip Cancer. International journal of radiation oncology, biology, physics, 83(4), pp. 1205-12. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2011.09.038
Ghadjar, Pirus; Simcock, Mathew; Zimmermann, Frank; Betz, Michael; Bodis, Stephan; Bernier, Jacques; Studer, Gabriela; Aebersold, Daniel M; Swiss Group for Clinical Cancer Research (SAKK), (2012). Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiotherapy and oncology, 104(2), pp. 213-8. Amsterdam: Elsevier 10.1016/j.radonc.2012.05.004
Schoenewolf, Nicola L; Dummer, Reinhard; Mihic-Probst, Daniela; Moch, Holger; Simcock, Mathew; Ochsenbein, Adrian; Gillessen, Silke; Schraml, Peter; von Moos, Roger; Swiss Group for Clinical Cancer Research, (SAKK) (2012). Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques. Case reports in oncology, 5(2), pp. 280-9. Basel: Karger 10.1159/000339300
Schraml, Peter; von Teichman, Adriana; Mihic-Probst, Daniela; Simcock, Mathew; Ochsenbein, Adrian; Dummer, Reinhard; Michielin, Olivier; Seifert, Bettina; Schläppi, Marc; Moch, Holger; von Moos, Roger (2012). Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncology reports, 28(2), pp. 654-8. Athens: National Hellenic Research Foundation 10.3892/or.2012.1826
Madlung, Axel; Simcock, Mathew; Ghadjar, Pirus (2011). Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer, 117(15), 3532; author reply 3532-3. New York, N.Y.: John Wiley & Sons 10.1002/cncr.25456
Ghadjar, Pirus; Schreiber-Facklam, Heide; Gräter, Ruth; Evers, Christina; Simcock, Mathew; Geretschläger, Andreas; Blumstein, Norbert M; Zbären, Peter; Zimmer, Yitzhak; Wilkens, Ludwig; Aebersold, Daniel M (2010). Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. International journal of radiation oncology, biology, physics, 76(4), pp. 1127-32. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2009.03.065
Ghadjar, Pirus; Simcock, Mathew; Schreiber-Facklam, Heide; Zimmer, Yitzhak; Gräter, Ruth; Evers, Christina; Arnold, Andreas; Wilkens, Ludwig; Aebersold, Daniel M (2010). Incidence of small lymph node metastases with evidence of extracapsular extension: clinical implications in patients with head and neck squamous cell carcinoma. International journal of radiation oncology, biology, physics, 78(5), pp. 1366-72. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2009.07.411
Koeberle, Dieter; Montemurro, Michael; Samaras, Panagiotis; Majno, Pietro; Simcock, Mathew; Limacher, Andreas; Lerch, Stefanie; Kovàcs, Katalin; Inauen, Roman; Hess, Vivianne; Saletti, Piercarlo; Borner, Markus; Roth, Arnaud; Bodoky, György (2010). Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). Oncologist, 15(3), pp. 285-92. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2009-0316
Ghadjar, Pirus; Blank-Liss, Wieslawa; Simcock, Mathew; Hegyi, Ivan; Beer, Karl T; Moch, Holger; Aebersold, Daniel M; Zimmer, Yitzhak (2009). MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. Clinical & experimental metastasis, 26(7), pp. 809-15. Dordrecht: Springer Netherlands 10.1007/s10585-009-9280-9
Fux, Christoph A; Rauch, Andri; Simcock, Mathew; Bucher, Heiner C; Hirschel, Bernard; Opravil, Milos; Vernazza, Pietro; Cavassini, Matthias; Bernasconi, Enos; Elzi, Luigia; Furrer, Hansjakob (2008). Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral therapy, 13(8), pp. 1077-82. London: International Medical Press
Schuller, Jan C.; Brauchli, Peter; Dietrich, Daniel; Herrmann, Richard; Klingbiel, Dirk; Lerch, Stefanie; Mayer, Michael; Simcock, Mathew; Hsu Schmitz, Shu-Fang (2009). Should phase II cancer screening trials include a control arm? 30th Annual Conference of the International Society for Clinical Biostatistics, August 23-27, 2009, Prague.
